Martingale Asset Management L P Halozyme Therapeutics, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$32.86 - $55.7 $29,606 - $50,185	901 Added 6.38%	15,021 $573,000
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $52,198 - $77,450	1,303 Added 10.17%	14,120 $803,000
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $292,712 - $393,372	7,597 Added 145.54%	12,817 $507,000
Q2 2022 Aug 11, 2022	BUY	$37.35 - $48.3 $194,967 - $252,125	5,220 New	5,220 $229,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.